alexa Editor - Leandro Bueno Bergantin | Universidade Federal de São | 23902
ISSN: 2472-100X

Journal of Pediatric Neurology and Medicine
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
View More»

Leandro Bueno Bergantin

Leandro Bueno Bergantin Leandro Bueno Bergantin
Department of Pharmacology Rua Pedro de Toledo
Universidade Federal de São Paulo

Dr. Bergantin received his academic education at EPM-UNIFESP (Brazil) and UAM (Spain): Degree in biomedicine (2008), MSc (2010) and PhD (2014). His research work solved the enigma of the paradoxical effects produced by L-type Ca2+ channel blockers (TOP 25 Hottest Articles - Biochemistry, Genetics and Molecular Biology - Cell Calcium - TOP 1 July to September 2013/ TOP 5 October to December 2013/ TOP 1 January to December 2013 full year/TOP 6 January to March 2014). Since 1975, several clinical and experimental studies have reported that acute and chronic administration of L-type Ca2+ channel blockers (CCB), such as nifedipine, produces reduction in arterial pressure associated with a paradoxical increase of sympathetic activity. Despite this sympathetic hyperactivity has been initially attributed to adjust reflex of arterial pressure, the cellular and molecular mechanisms involved in this apparent sympathomimetic effect of the Ltype CCB remained unclear for decades. In 2013, Dr. Bergantin and collaborators discovered that this paradoxical increase in sympathetic activity produced by L-type CCB is due to interaction of the Ca2+/cAMP signaling pathways. Then, the pharmacological manipulation of the Ca2+/cAMP interaction produced by combination of the L-type CCB used in the antihypertensive therapy, and cAMP accumulating compounds used in the antidepressive therapy, could represent a potential cardiovascular risk for hypertensive patients due to increase in sympathetic activity. In contrast, this pharmacological manipulation could be a new therapeutic strategy for increasing neurotransmission in psychiatric disorders, and producing neuroprotection in the neurodegenerative diseases (Bergantin and Caricati-Neto, 2016 Eur J Pharmacol; Caricati-Neto et al., 2015 Pharm Res Perspect). Dr. Bergantin has published several articles in international journals (> 30), book chapters and an international book. He is member of several editorial boards of international journals (> 40, including editor-in-chief of 2 international journals). Dr. Bergantin has been frequently invited (every week) to be honorable guest (speaker) in international conferences.

Research Interest

Neuropsychopharmacology, autonomic and cardiovascular pharmacology, cell signaling mediated by Ca2+ and cAM.



Revisiting the Clinical Link Between Alzheimer's Disease and Depression Through the Ca2+/Camp Signalling Interaction
Leandro Bueno Bergantin
Editorial: Brain Disord Ther 2018, 7:e127
DOI: 10.4172/2168-975X.1000e127
Dysregulation of Intracellular Ca2+ and Camp Signalling: Plausible Targets for Neurological Disorders
Leandro Bueno Bergantin
Editorial: J Neurol Disord 2017, 5:e125
DOI: 10.4172/2329-6895.1000e125
What can We Expect for The Therapy of Neurological and Psychiatric Diseases in 2018?
Leandro Bueno Bergantin
Editorial: Brain Disord Ther 2018, 7:e126
DOI: 10.4172/2168-975X.1000e126
Neurological Disorders: Is There a Horizon? Emerging Ideas from the Interaction between Ca2+ and Camp Signaling Pathways
Leandro Bueno Bergantin
Editorial: J Neurol Disord 2017, 5:e124
DOI: 10.4172/2329-6895.1000e124
Neurodegenerative Diseases: Where To Go From Now? Thought Provoking Through Ca2+/cAMP Signaling Interaction
Leandro Bueno Bergantin
Editorial: Brain Disord Ther 2017, 6:e125
DOI: 10.4172/2168-975X.1000e125
Potential Cardioprotective Effects of Orlistat for Treatment of Myocardial Infarction
Francisco Sandro Menezes-Rodrigues1, José Gustavo Padrão Tavares1, Erisvaldo Amarante de Araújo1, Luciana de Paula2, Paolo Ruggero Errante1, Afonso Caricati-Neto1 and Leandro Bueno Bergantin1*
Editorial: J Thrombo Cir, 3-e108
DOI: 10.4172/2572-9462.1000e108
The Second Messengers Ca2+ and camp as Potential Therapeutic Targets for the Control of Cancer Progression
Paolo Ruggero Errante, Francisco Sandro Menezes-Rodrigues, Alberto Andrade Leite, Afonso Caricati-Neto and Leandro Bueno Bergantin
Editorial: Adv Cancer Prev 2: e105
Extracellular Cyclic AMP/Adenosine Signaling Pathway: A Potential Pharmacological Target for Therapeutic Intervention in Chronic Lymphocytic Leukemia
Francisco Sandro Menezes-Rodrigues, Paolo Ruggero Errante, Afonso Caricati-Neto and Leandro Bueno Bergantin
Editorial: Adv Cancer Prev 2: e104
DOI: 10.4172/2472-0429.1000e104
A Simple and Efficient Methodology for the Study of Cardioprotective Drugs in Animal Model of Cardiac Ischemia-Reperfusion
José Gustavo Padrão Tavares, Francisco Sandro Menezes-Rodrigues, Ênio Rodrigues Vasques, Maria do Carmo Maia Reis, Luciana de Paula, Bráulio Luna-Filho, Paolo Ruggero Errante, Afonso Caricati-Neto and Leandro Bueno Bergantin
Research Article: J Mol Imaging Dynam 2017,7: 133
DOI: 10.4172/2155-9937.1000133
Sudden Unexpected Death in Parkinson’s Disease and the Pharmacological Modulation of the Ca2+/cAMP Signaling Interaction: A Shot of Good News
Afonso Caricati-Neto1, Fúlvio Alexandre Scorza2 ,Carla Alessandra Scorza2, Roberta Monterazzo Cysneiros3, Francisco Sandro Menezes- Rodrigues1, and Leandro Bueno Bergantin1*
Short Communication: Brain Disord Ther 2017, 6:231
DOI: 10.4172/2168-975X.1000231
Insights for the Inhibition of Cancer Progression: Revisiting Ca2+ and Camp Signalling Pathways
Paolo Ruggero Errante, Afonso Caricati-Neto and Leandro Bueno Bergantin
Editorial: Adv Cancer Prev 2: e103
DOI: 10.4172/2472-0429.1000e103
A 4-Decade Enigma, Two Researchers and a Wonderful History
Leandro Bueno Bergantin and Afonso Caricati-Neto
Editorial: Fam Med Med Sci Res 2017, 6:e109
DOI: 10.4172/2327-4972.1000e109
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A


[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


porn sex

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

Gaziantep Escort

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A


[email protected]

1-702-714-7001Extn: 9037


James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

mp3 indir

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals


Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T


[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version